Chester County News and Community Website
WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) has confirmed its first-quarter 2025 financial results will be released on Tuesday, April 29, 2025. A conference call and webcast to discuss …
Incyte to Announce Q1 2025 Financial Results on April 29 Read More WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) recently awarded restricted stock units (RSUs) totaling 20,334 shares of common stock to 24 newly hired employees. These awards were granted as …
Incyte Grants Restricted Stock Units to New Employees Read More WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) has reported encouraging results from its Phase 3 STOP-HS clinical trials evaluating povorcitinib, an oral JAK1 inhibitor, for moderate to severe hidradenitis suppurativa …
Incyte Announces Positive Phase 3 Results for Hidradenitis Suppurativa Treatment Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) announced its expansion in Delaware with the acquisition of two buildings in downtown Wilmington. Located at 1100 North King Street and 1100 North French …
Incyte Expands Delaware Presence with New Wilmington Buildings Read More